Skip to main content

Advertisement

Log in

Results of surgery plus postoperative radiotherapy for patients with malignant parotid tumor

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

The latest version of the World Health Organization (WHO) histologic classification of salivary gland malignancies was published in 2005. To contribute to data accumulation on the basis of this latest version, a retrospective study was performed.

Materials and methods

Participants comprised 27 patients who underwent postoperative radiotherapy between 2000 and 2013. Two, eight, and 17 patients were allocated to low, intermediate, and high-grade groups, respectively, in accordance with the latest WHO classification. The radiation field included the tumor bed and ipsilateral regional lymph nodes for 25 patients. The radiation dose was 46–60 Gy (median 56 Gy).

Results

Median duration of follow-up was 41 months. Five-year locoregional control was 89 %. Two patients experienced local recurrence and 7 patients developed distant metastases. No patients in the low or intermediate-grade groups developed distant metastases. Overall 3 and 5-year survival for all patients were 81 and 75 %, respectively. Five-year overall survival for patients in the low and intermediate-grade groups was 100 %, compared with 59 % for patients in the high-grade group (p = 0.03).

Conclusion

Favorable locoregional control was achieved for patients with malignant parotid tumors who underwent surgery plus postoperative radiotherapy. Patients with high-grade tumors frequently experienced distant metastases and prognosis was poor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary parotid malignancies. A clinical and pathologic review. Arch Otolaryngol Head Neck Surg. 1991;117:307–15.

    Article  CAS  PubMed  Google Scholar 

  2. Brandwein MS, Ferlito A, Bradley PJ, Hille JJ, Rinaldo A. Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes. Acta Otolaryngol. 2002;122:758–64.

    Article  PubMed  Google Scholar 

  3. Barnes L, Eveson JW, Reichart P, Sidransky D. (eds.) World Health Organization classification of tumours: pathology genetics. head and neck tumours. International Agency for Research on Cancer (IARC). Lyon: IARC Press. 2005;221–2.

  4. Terhaard CH, Lubsen H, Rasch CR, Levendag PC, Kaanders HH, Tjho-Heslinga RE, et al. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys. 2005;61:103–11.

    Article  PubMed  Google Scholar 

  5. Agulnik M, McGann C, Mittal B, Gordon S, Epstein J. Management of salivary gland malignancies: current and developing therapies. Oncol Rev. 2008;2:86–94.

    Article  Google Scholar 

  6. Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY. Malignant tumors of major salivary gland origin: a matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg. 1990;116:290–3.

    Article  CAS  PubMed  Google Scholar 

  7. Harrison LB, Armstrong JG, Spiro RH, Fass DE, Strong EW. Postoperative radiation therapy for major salivary gland malignancies. J Surg Oncol. 1990;45:52–5.

    Article  CAS  PubMed  Google Scholar 

  8. Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB, et al. The development of a prognostic score for patients with parotid carcinoma. Cancer. 1999;85:2057–67.

    Article  CAS  PubMed  Google Scholar 

  9. Al-Mamgani A, Van Rooij P, Verduijn GM, Meeuwis CA, Levendag PC. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center. Int J Radiat Oncol Biol Phys. 2012;84:189–95.

    Article  PubMed  Google Scholar 

  10. Licitra L, Marchini S, Spinazzè S, Rossi A, Rocca A, Grandi C, et al. Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients. Cancer. 1991;68:1874–7.

    Article  CAS  PubMed  Google Scholar 

  11. Airoldi M, Pedani F, Succo G, Gabriele AM, Ragona R, Marchionatti S, et al. Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies. Cancer. 2001;91:541–7.

    Article  CAS  PubMed  Google Scholar 

  12. Fu KK, Leibel SA, Levine ML, Friedlander LM, Boles R, Phillips TL. Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Cancer. 1977;40:2882–90.

    Article  CAS  PubMed  Google Scholar 

  13. Fitzpatrick PJ, Theriault C. Malignant salivary gland tumors. Int J Radiat Oncol Biol Phys. 1986;12:1743–7.

    Article  CAS  PubMed  Google Scholar 

  14. Tran L, Sadeghi A, Hanson D, Juillard G, Mackintosh R, Calcaterra TC, et al. Major salivary gland tumors: treatment results and prognostic factors. Laryngoscope. 1986;96:1139–44.

    Article  CAS  PubMed  Google Scholar 

  15. Frankenthaler RA, Luna MA, Lee SS, Ang KK, Byers RM, Guillamondegui OM, et al. Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg. 1991;117:1251–6.

    Article  CAS  PubMed  Google Scholar 

  16. Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB. Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer. 2005;103:2544–50.

    Article  PubMed  Google Scholar 

  17. Pohar S, Gay H, Rosenbaum P, Klish D, Bogart J, Sagerman R, et al. Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes. Int J Radiat Oncol Biol Phys. 2005;61:112–8.

    Article  PubMed  Google Scholar 

  18. Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006;66:152–9.

    Article  PubMed  Google Scholar 

  19. Arrangoiz R, Papavasiliuo P, Sarcu D, Galloway TJ, Ridge JA, Lango M. Current thinking on malignant salivary gland neoplasms. J Cancer Treat Res. 2013;1:8–24.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shogo Matsuda.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical statement

All applicable institutional guidelines for the care were followed.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsuda, S., Iguchi, H., Tada, T. et al. Results of surgery plus postoperative radiotherapy for patients with malignant parotid tumor. Jpn J Radiol 33, 533–537 (2015). https://doi.org/10.1007/s11604-015-0450-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-015-0450-1

Keywords

Navigation